Matthew Sevensma
Cardiovascular Disease · Wyoming, MINPI 1255312302
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,650 of the $2,471 with a category attached, or 66.7%. 9 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 59.8% of the total. Reporting peaked in 2019 at $2,072 and has fallen 91.3% since, to $181 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in MI, where the typical reported total is $2,775.
Across 18 payments — averaging $137.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$1K
- Artivion, Inc.$423
- Abbott$203
- Medtronic$145
- Biotronik Inc.$88
- Boston Scientific$39
- plus $94 from 3 others
Across 350 payments — averaging $402.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Elutia, Inc.$47K
- ZOLL Respicardia, Inc.$44K
- Biotronik Inc.$33K
- Boston Scientific$17K
What the payments were for
- Travel & lodging$1,65067%
- Food & beverage$82233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Respicardia, Inc. | 2 | $1,478 |
| Artivion, Inc. | 1 | $423 |
| Abbott | 3 | $203 |
| Medtronic | 2 | $145 |
| Biotronik Inc. | 4 | $88 |
| Boston Scientific | 1 | $39 |
| Shockwave Medical, Inc | 2 | $37 |
| Edwards Lifesciences | 1 | $32 |
| Elutia, Inc. | 2 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$1,478
- AVEIR$137
- LINQ II$107
How this compares
$2,471 in reported general payments places this provider in the 45th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 478 | $563,157 |
| JardianceEmpagliflozin | 312 | $341,213 |
| XareltoRivaroxaban | 175 | $197,813 |
| EntrestoSacubitril/Valsartan | 188 | $189,410 |
| FarxigaDapagliflozin Propanediol | 63 | $61,892 |
| Metoprolol Succinate | 398 | $12,022 |
| Repatha SureclickEvolocumab | 16 | $12,011 |
| Ranolazine ErRanolazine | 47 | $6,939 |
| Atorvastatin Calcium | 290 | $5,337 |
| Famotidine | 141 | $4,642 |
| Potassium Chloride | 110 | $4,393 |
| ClopidogrelClopidogrel Bisulfate | 184 | $3,749 |
| Carvedilol | 180 | $3,142 |
| Rosuvastatin Calcium | 122 | $2,479 |
| Midodrine Hcl | 17 | $2,362 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Wyoming
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- David StroblLansing$445K
- Herman KadoSouthfield$442K
- Douglas HorstmanshofRoyal Oak$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.